vs
Side-by-side financial comparison of Primis Financial Corp. (FRST) and Inogen Inc (INGN). Click either name above to swap in a different company.
Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $45.6M, roughly 1.5× Primis Financial Corp.). Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs 4.2%).
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
FRST vs INGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.6M | $68.6M |
| Net Profit | $7.3M | — |
| Gross Margin | — | 51.4% |
| Operating Margin | — | -13.6% |
| Net Margin | 16.0% | — |
| Revenue YoY | — | 3.4% |
| Net Profit YoY | -61.6% | — |
| EPS (diluted) | $0.30 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $68.6M | ||
| Q3 25 | $41.0M | $79.1M | ||
| Q2 25 | $43.2M | $79.2M | ||
| Q1 25 | $58.7M | $68.5M | ||
| Q4 24 | $38.8M | $66.3M | ||
| Q3 24 | $37.3M | $74.9M | ||
| Q2 24 | $35.7M | $74.4M |
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | — | ||
| Q3 25 | $6.8M | $-5.3M | ||
| Q2 25 | $2.4M | $-4.2M | ||
| Q1 25 | $22.6M | $-6.2M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $1.2M | $-6.0M | ||
| Q2 24 | $3.4M | $-5.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% |
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | -13.6% | ||
| Q3 25 | 21.3% | -9.0% | ||
| Q2 25 | 6.9% | -7.7% | ||
| Q1 25 | 41.9% | -11.2% | ||
| Q4 24 | -123.0% | -17.2% | ||
| Q3 24 | -3.1% | -10.4% | ||
| Q2 24 | 7.8% | -9.5% |
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 16.7% | -6.7% | ||
| Q2 25 | 5.6% | -5.2% | ||
| Q1 25 | 38.6% | -9.0% | ||
| Q4 24 | -100.3% | — | ||
| Q3 24 | 3.3% | -8.0% | ||
| Q2 24 | 9.6% | -7.5% |
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $-0.26 | ||
| Q3 25 | $0.28 | $-0.20 | ||
| Q2 25 | $0.10 | $-0.15 | ||
| Q1 25 | $0.92 | $-0.25 | ||
| Q4 24 | $-0.95 | $-0.41 | ||
| Q3 24 | $0.05 | $-0.25 | ||
| Q2 24 | $0.14 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.9M | $103.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $427.2M | $192.2M |
| Total Assets | $4.3B | $298.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $103.7M | ||
| Q3 25 | $63.9M | $106.5M | ||
| Q2 25 | $94.1M | $103.7M | ||
| Q1 25 | $57.0M | $118.9M | ||
| Q4 24 | $64.5M | $113.8M | ||
| Q3 24 | $77.3M | $105.7M | ||
| Q2 24 | $66.6M | $97.9M |
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $192.2M | ||
| Q3 25 | $382.2M | $197.2M | ||
| Q2 25 | $376.4M | $199.5M | ||
| Q1 25 | $375.6M | $198.0M | ||
| Q4 24 | $351.8M | $173.9M | ||
| Q3 24 | $381.0M | $185.4M | ||
| Q2 24 | $376.0M | $187.6M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $298.6M | ||
| Q3 25 | $4.0B | $307.0M | ||
| Q2 25 | $3.9B | $312.0M | ||
| Q1 25 | $3.7B | $308.4M | ||
| Q4 24 | $3.7B | $296.2M | ||
| Q3 24 | $4.0B | $306.2M | ||
| Q2 24 | $4.0B | $308.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $-943.0K | ||
| Q3 25 | $-11.4M | $2.2M | ||
| Q2 25 | $-41.0M | $4.3M | ||
| Q1 25 | $34.4M | $-16.8M | ||
| Q4 24 | $19.5M | $-3.0M | ||
| Q3 24 | $6.1M | $7.0M | ||
| Q2 24 | $52.3M | $6.7M |
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | $-1.9M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-17.1M | ||
| Q4 24 | $18.3M | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M |
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | -2.8% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | -24.9% | ||
| Q4 24 | 47.3% | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | 3.1% | 0.5% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.0% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | — | ||
| Q3 25 | -1.67× | — | ||
| Q2 25 | -16.82× | — | ||
| Q1 25 | 1.52× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.93× | — | ||
| Q2 24 | 15.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
